Market Overview:
The global POC cardiovascular diagnostic market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cardiovascular diseases, technological advancements in POC diagnostics, and rising demand for point-of-care diagnostics. The global POC cardiovascular diagnostic market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into diagnostic equipment and diagnostic reagents. The diagnostic equipment segment is further subsegmented into ECG machines, Echocardiography machines, Holter monitors & event recorders Cardiac stress test systems), Arrhythmia detectors (electrocardiographs), Blood pressure monitors & sphygmomanometers) and others). The Diagnostic Reagents Segment Is Further Subdivided Into Cardiac Markers ( Troponin I/T assay kits , CKMB assay kit ), Lipid Profile Tests ( Total cholesterol assay kit , HDL cholesterol assay kit ), Glucose Test Kits ( Glucose oxidase method test kit 、 Hexokinase method test kit ) And Others .On The Basis Of Application ,The Market Is Segmented Into Hospital Clinics And Other .Geographically ,the Global PoC Cardiovascular Diagnostic Market Is Divided Into North America Latin America Europe Asia Pacific And Middle East Africa .
Product Definition:
A POC Cardiovascular Diagnostic is a handheld device used to measure the electrical activity of the heart. This information can be used to diagnose and monitor various cardiovascular conditions. The importance of POC Cardiovascular Diagnostics lies in their ability to provide fast, accurate results that can help healthcare professionals make informed decisions about patient care.
Diagnostic Equipment:
Diagnostic equipment is used for the detection of disease or medical condition. It includes a wide range of devices such as blood pressure monitors, glucometer, thermometers, ECG machines and other imaging devices. The global diagnostic equipment market is expected to witness significant growth over the forecast period owing to increasing prevalence of cardiovascular diseases (CVDs) globally and rising demand for point-of-care (POC) testing.
Diagnostic Reagents:
The global diagnostic reagents market is expected to witness significant growth over the forecast period. The key drivers attributing to the growth of this market include growing prevalence of cardiovascular diseases, increasing demand for point-of-care (POC) diagnostics, and rising R&D activities in molecular diagnostics.
Application Insights:
The hospital-based segment dominated the global market in 2017. This can be attributed to factors such as presence of key players, high prevalence of Cardiovascular Diseases (CVDs) and increasing government initiatives for improving healthcare infrastructure at the national level. For instance, National Infrastructure Protection Plan (NIPP) is a U.S. Department of Homeland Security directive issued on September 14, 2002 that requires federal agencies to identify Critical Infrastructure and Key Resource (CIKR) facilities and develop a plan to protect these assets from cyber-attacks or other acts of violence. According to this directive, protecting CIKR facilities includes developing strategies for preventing terrorist attacks against these assets as well as preparing responses during emergencies involving terrorism or natural disasters such as earthquakes or floods among others¢â‚¬â„¢ activities are carried out at hospitals which include emergency services, trauma care centers etc.
Regional Analysis:
North America dominated the global POC cardiovascular diagnostic market in 2017. This can be attributed to favorable reimbursement policies, well-established healthcare infrastructure, and increasing prevalence of target diseases. Moreover, rising adoption of advanced technologies and high per capita healthcare expenditure are also contributing toward regional growth.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to improving healthcare infrastructure and growing patient awareness levels regarding early diagnosis of heart diseases. Furthermore, government initiatives for creating awareness about POC diagnostics are also anticipated to drive regional demand during the forecast period. For instance, ‘World Heart Day’ is being celebrated on 4th November every year in Japan as a reminder for individuals about their health & safety when having any cardiac symptoms such as shortness of breath or chest pain etc., which further increases the risk for developing heart failure or sudden cardiac arrest (SCA).
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Growing geriatric population
- Rising awareness about early diagnosis and treatment of CVDs
- Technological advancements in POC CV diagnostics
- Increasing demand for point-of-care cardiac biomarkers
Scope Of The Report
Report Attributes
Report Details
Report Title
POC Cardiovascular Diagnostic Market Research Report
By Type
Diagnostic Equipment, Diagnostic Reagents
By Application
Hospital, Clinic, Other
By Companies
Abbott, Biomerieux, Danaher, F. Hoffmann-La Roche, Siemens, Abbott
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global POC Cardiovascular Diagnostic Market Report Segments:
The global POC Cardiovascular Diagnostic market is segmented on the basis of:
Types
Diagnostic Equipment, Diagnostic Reagents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Biomerieux
- Danaher
- F. Hoffmann-La Roche
- Siemens
- Abbott
Highlights of The POC Cardiovascular Diagnostic Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diagnostic Equipment
- Diagnostic Reagents
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the POC Cardiovascular Diagnostic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
POC Cardiovascular Diagnostic is a diagnostic tool that uses computer algorithms to identify cardiovascular abnormalities in patients.
Some of the major players in the poc cardiovascular diagnostic market are Abbott, Biomerieux, Danaher, F. Hoffmann-La Roche, Siemens, Abbott.
The poc cardiovascular diagnostic market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 POC Cardiovascular Diagnostic Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 POC Cardiovascular Diagnostic Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 POC Cardiovascular Diagnostic Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the POC Cardiovascular Diagnostic Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global POC Cardiovascular Diagnostic Market Size & Forecast, 2018-2028
4.5.1 POC Cardiovascular Diagnostic Market Size and Y-o-Y Growth
4.5.2 POC Cardiovascular Diagnostic Market Absolute $ Opportunity
Chapter 5 Global POC Cardiovascular Diagnostic Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 POC Cardiovascular Diagnostic Market Size Forecast by Type
5.2.1 Diagnostic Equipment
5.2.2 Diagnostic Reagents
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global POC Cardiovascular Diagnostic Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 POC Cardiovascular Diagnostic Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global POC Cardiovascular Diagnostic Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 POC Cardiovascular Diagnostic Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America POC Cardiovascular Diagnostic Analysis and Forecast
9.1 Introduction
9.2 North America POC Cardiovascular Diagnostic Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America POC Cardiovascular Diagnostic Market Size Forecast by Type
9.6.1 Diagnostic Equipment
9.6.2 Diagnostic Reagents
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America POC Cardiovascular Diagnostic Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe POC Cardiovascular Diagnostic Analysis and Forecast
10.1 Introduction
10.2 Europe POC Cardiovascular Diagnostic Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe POC Cardiovascular Diagnostic Market Size Forecast by Type
10.6.1 Diagnostic Equipment
10.6.2 Diagnostic Reagents
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe POC Cardiovascular Diagnostic Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific POC Cardiovascular Diagnostic Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific POC Cardiovascular Diagnostic Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific POC Cardiovascular Diagnostic Market Size Forecast by Type
11.6.1 Diagnostic Equipment
11.6.2 Diagnostic Reagents
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific POC Cardiovascular Diagnostic Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America POC Cardiovascular Diagnostic Analysis and Forecast
12.1 Introduction
12.2 Latin America POC Cardiovascular Diagnostic Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America POC Cardiovascular Diagnostic Market Size Forecast by Type
12.6.1 Diagnostic Equipment
12.6.2 Diagnostic Reagents
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America POC Cardiovascular Diagnostic Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) POC Cardiovascular Diagnostic Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) POC Cardiovascular Diagnostic Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) POC Cardiovascular Diagnostic Market Size Forecast by Type
13.6.1 Diagnostic Equipment
13.6.2 Diagnostic Reagents
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) POC Cardiovascular Diagnostic Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 POC Cardiovascular Diagnostic Market: Competitive Dashboard
14.2 Global POC Cardiovascular Diagnostic Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Biomerieux
14.3.3 Danaher
14.3.4 F. Hoffmann-La Roche
14.3.5 Siemens
14.3.6 Abbott
